Tompkins, AK, Cooke, DT, Backhus, L, DiMaio, JM, Pereira, SJ, Antonoff, MB , Merrill, WH, Erkmen, CP, Pereira, SJ, Backhus, LM, Bostock Rosenzweig, IC, Bowen, D, Cooke, DT, Erhunmwunsee, L, Freeman, KA, Godoy, L, Kozik, D, Kpodonu, J, Lagisetty, KH, Pelletier, GJ, Sihag, S, Wallace, AF, Wilder, F, Wood, DE, Arora, A, Boffa, DJ, Kaiser, LR, Macheers, SK, Martin, LW, Misselbeck, TS, Spurlock, DJ, Squiers, J, Reece, TB, Okusanya, O, Tong, BC, Gillaspie, EA, Fiedler, A, Kidane, B, Kim, MP, Krueger, A, Mitzman, B, Mokadam, NA, Pal, J, Vardas, P, Yang, SC, Dexter, E, Rove, J, Saddoughi, SA, Serna-Gallegos, D, Nelson, DB
GLP-1 meds slow digestion
Improved blood sugar control Research conducted on humans has demonstrated that glucagon-like peptide-1 and its analogues can significantly improve blood sugar control through various mechanisms
Maintaining an optimal level of glutathione appears to be important for supporting cognitive function, especially during aging.* The normal process of aging is associated with a decrease in glutathione activity, which can result in increased oxidative activity.* Less than an optimum level of glutathione is observed in individuals experiencing a decline in cognitive function.* Conversely, individuals who live to 100 tend to have higher glutathione activity.*